Access of inhibitory neurosteroids to the NMDA receptor

British Journal of Pharmacology

Volumn 166, Issue 3, 2012, Pages 1069-1083

  Borovska, Jirina ^a   Vyklicky, Vojtech ^a   Stastna, Eva ^b   Kapras, Vojtech ^b   Slavikova, Barbora ^b   Horak, Martin ^a   Chodounska, Hana ^b,c   Vyklicky, Ladislav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

fluorescent steroid analogues; inhibition; neurosteroids; NMDA receptor; patch clamp recording; pregnane analogues; recombinant receptors

Indexed keywords

3ALPHA AZIDO 5BETA PREGNAN 20 ONE; 5BETA PREGNAN 20 ONE 3ALPHA YL NITRATE; BETA CYCLODEXTRIN; GAMMA CYCLODEXTRIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; PA 11; PA 12; PA 13; PA 14; PA 15; PA 17; PA 18; PA 21; PA 22; PA 25; PA 27; PA 33; PA 34; PA 35; PA 36; PA 4; PA 5; PA 6; PREGNANOLONE SULPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; HIPPOCAMPUS; HORMONE INHIBITION; HUMAN; HUMAN CELL; IC 50; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

EID: 84860879085     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01816.x     Document Type: Article

References (43)

1. Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, et al,. (2002). Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 45: 1806-1816.
2. Akk G, Shu HJ, Wang C, Steinbach JH, Zorumski CF, Covey DF, et al,. (2005). Neurosteroid access to the GABAA receptor. J Neurosci 25: 11605-11613.
3. th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Besshoh S, Chen S, Brown IR, Gurd JW, (2007). Developmental changes in the association of NMDA receptors with lipid rafts. J Neurosci Res 85: 1876-1883.
5. Blouin A, Bolender RP, Weibel ER, (1977). Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 72: 441-455.
6. Bullock AE, Clark AL, Grady SR, Robinson SF, Slobe BS, Marks MJ, et al,. (1997). Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68: 2412-2423.
7. Cais O, Sedlacek M, Horak M, Dittert I, Vyklicky L Jr, (2008). Temperature dependence of NR1/NR2B NMDA receptor channels. Neuroscience 151: 428-438.
8. Casado M, Ascher P, (1998). Opposite modulation of NMDA receptors by lysophospholipids and arachidonic acid: common features with mechanosensitivity. J Physiol (Lond) 513: 317-330.
9. Chattopadhyay A, (1990). Chemistry and biology of N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)-labeled lipids: fluorescent probes of biological and model membranes. Chem Phys Lipids 53: 1-15.
10. Chisari M, Eisenman LN, Krishnan K, Bandyopadhyaya AK, Wang C, Taylor A, et al,. (2009). The influence of neuroactive steroid lipophilicity on GABAA receptor modulation: evidence for a low-affinity interaction. J Neurophysiol 102: 1254-1264.
11. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE, (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A 78: 4704-4707.
12. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, et al,. (2010). Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021-1026.
13. Flood JF, Roberts E, (1988). Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 448: 178-181.
14. Grobin AC, Roth RH, Deutch AY, (1992). Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3a,21-dihydroxy-5a-pregnane- 20-one. Brain Res 578: 351-356.
15. Korade Z, Kenworthy AK, (2008). Lipid rafts, cholesterol, and the brain. Neuropharmacology 55: 1265-1273.
16. Kostakis E, Jang MK, Russek SJ, Gibbs TT, Farb DH, (2011). A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons. J Neurochem 119: 486-496.
17. Kussius CL, Kaur N, Popescu GK, (2009). Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J Neurosci 29: 6819-6827.
18. Lapchak PA, (2004). The neuroactive steroid 3-alpha-ol-5-beta-pregnan-20- one hemisuccinate, a selective NMDA receptor antagonist improves behavioral performance following spinal cord ischemia. Brain Res 997: 152-158.
19. Mayer ML, Westbrook GL, Guthrie PB, (1984). Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309: 261-263.
20. Nasman B, Olsson T, Backstrom T, Eriksson S, Grankvist K, Viitanen M, et al,. (1991). Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 30: 684-690.
21. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A, (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307: 462-465.
22. Ogden KK, Traynelis SF, (2011). New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32: 726-733.
23. Park-Chung M, Wu FS, Farb DH, (1994). 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 46: 146-150.
24. Petrovic M, Sedlacek M, Horak M, Chodounska H, Vyklicky L Jr, (2005). 20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor. J Neurosci 25: 8439-8450.
25. Popescu G, (2005). Mechanism-based targeting of NMDA receptor functions. Cell Mol Life Sci 62: 2100-2111.
26. Reddy DS, (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186: 113-137.
27. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
28. Rupprecht R, Holsboer F, (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410-416.
29. Salous AK, Ren H, Lamb KA, Hu XQ, Lipsky RH, Peoples RW, (2009). Differential actions of ethanol and trichloroethanol at sites in the M3 and M4 domains of the NMDA receptor GluN2A (NR2A) subunit. Br J Pharmacol 158: 1395-1404.
30. Sedlacek M, Korinek M, Petrovic M, Cais O, Adamusova E, Chodounska H, et al,. (2008). Neurosteroid modulation of ionotropic glutamate receptors and excitatory synaptic transmission. Physiol Res 57 (Suppl. 3): S49-S57.
31. Shu HJ, Eisenman LN, Jinadasa D, Covey DF, Zorumski CF, Mennerick S, (2004). Slow actions of neuroactive steroids at GABAA receptors. J Neurosci 24: 6667-6675.
32. Sobolevsky AI, Rosconi MP, Gouaux E, (2009). X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462: 745-756.
33. Stastna E, Chodounska H, Pouzar V, Kapras V, Borovska J, Cais O, et al,. (2009). Synthesis of C3, C5, and C7 pregnane derivatives and their effect on NMDA receptor responses in cultured rat hippocampal neurons. Steroids 74: 256-263.
34. Szejtli J, (1998). Introduction and General Overview of Cyclodextrin Chemistry. Chem Rev 98: 1743-1754.
35. Tetko IV, (2005). Computing chemistry on the web. Drug Discov Today 10: 1497-1500.
36. Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, et al,. (2005). Virtual computational chemistry laboratory-design and description. J Comput Aided Mol Des 19: 453-463.
37. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al,. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62: 405-496.
38. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, Koehl M, et al,. (1997). Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci U S A 94: 14865-14870.
39. Weaver CE Jr, Marek P, Park-Chung M, Tam SW, Farb DH, (1997). Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94: 10450-10454.
40. Wu FS, Gibbs TT, Farb DH, (1990). Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol 37: 597-602.
41. Wu FS, Gibbs TT, Farb DH, (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D- aspartate receptor. Mol Pharmacol 40: 333-336.
42. Yancey PG, Rodrigueza WV, Kilsdonk EP, Stoudt GW, Johnson WJ, Phillips MC, et al,. (1996). Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux. J Biol Chem 271: 16026-16034.
43. Zidovetzki R, Levitan I, (2007). Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324.